(Q48840378)

16 February 2018

editorial

0 references

title

BDNF/TrkB signaling as an anti-tumor target (English)

1 reference

16 February 2018

1 reference

16 February 2018

Gilberto Schwartsmann

1 reference

16 February 2018

author name string

Rafael Roesler

1 reference

16 February 2018

Caroline Brunetto de Farias

1 reference

16 February 2018

Algemir Lunardi Brunetto

1 reference

16 February 2018

publication date

1 October 2011

1 reference

16 February 2018

Expert Review of Anticancer Therapy

published in

1 reference

16 February 2018

volume

1 reference

16 February 2018

issue

1 reference

16 February 2018

page(s)

1473-1475

1 reference

16 February 2018

Trk receptors: roles in neuronal signal transduction

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.150

On Trk--the TrkB signal transduction pathway is an increasingly important target in cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.150

The neurotrophic receptor TrkB: a drug target in anti-cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.150

Trk receptor tyrosine kinases: a bridge between cancer and neural development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.150

BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.150

The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.150

Role and relevance of TrkB mutations and expression in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.150

Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.150

Brain-derived neurotrophic factor expression predicts adverse pathological & clinical outcomes in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.150

Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.150

Mutational analysis of the tyrosine kinome in colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.150

Functional Characterization of Human Cancer-Derived TRKB Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.150

BDNF/TrkB content and interaction with gastrin-releasing peptide receptor blockade in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.150

Brain-Derived Neurotrophic Factor Promotes Tumorigenesis via Induction of Neovascularization: Implication in Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.150

21 January 2018

Identifiers

DOI

10.1586/ERA.11.150

1 reference

16 February 2018

1 reference

16 February 2018